A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose Trivalent Inactivated Influenza Vaccine for Healthcare Workers
Phase of Trial: Phase I/II
Latest Information Update: 04 Feb 2019
Price : $35 *
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 22 Mar 2017 Status changed from active, no longer recruiting to completed.
- 12 Sep 2016 Planned End Date changed from 1 Apr 2016 to 1 Dec 2016.
- 13 Jan 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.